glp-1 and gip receptor agonist Potential Use of GIP/GLP-1 Agonists for Respiratory Disorders: Where Are We at? LY3437943, a novel triple glucagon,

Can amylin weight-loss drugs compete in a world of GLP-1s

Effect of truncated glucagonlike peptide1 [proglucagon(78107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach

60 Research has extensively examined the combined agonists of GLP-1 and GIP1-RA for their potential impact on diabetes management and weight reduction

Randomised controlled trial of fish oil supplementation on responsiveness to resistance exercise training in sarcopenic older women

The SUMMIT trial demonstrated that treatment with tirzepatide reduced the risk of a composite of cardiovascular-related deaths or worsening heart failure, compared with placebo, and improved the health of patients with heart failure with preserved ejection fraction and obesity [147]